From the ^∗Sexually Transmitted Diseases (STD) Control Branch, Division of Communicable Disease Control (DCDC), Center for Infectious Diseases (CID), California Department of Public Health (CDPH), Richmond

^†University of California San Francisco (UCSF), Department of Medicine, Division of Infectious Diseases, San Francisco, CA

Conflict of Interest: None declared.

Sources of Funding: This project was supported by funding from the U.S. Centers for Disease Control and Prevention's (CDC) Strengthening STD Prevention and Control for Health Departments (STD PCHD) cooperative agreement [PS19-1901].

Disclaimer: The findings and conclusions of this commentary are those of the authors and do not necessarily represent the views or opinions of the California Department of Public Health or the California Health and Human Services Agency.

Correspondence: Kelly A. Johnson, MD, MPH, UCSF Infectious Diseases, Rm S380, 513 Parnassus Ave., San Francisco, CA 94143. E-mail: [email protected].

Received for publication October 17, 2022, and accepted January 21, 2023.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (http://www.stdjournal.com).